We are using clinical examinations, MRI brain imaging and genetics to try to predict how severe your MS will be.
We want to remove the uncertainty that a diagnosis of MS can bring.
Scotland has one of the highest rates of multiple sclerosis (MS) in the world. An estimated 10,000 people in this country have this disabling condition.
When people are newly diagnosed with MS, they do not know what the future will hold. Most people experience occasional bouts of symptoms called 'relapses', but doctors cannot predict how often, and how severe, these relapses will be. This can make it difficult for people to make decisions about their lifestyle, work and family.
People with MS need a tool to predict - as early as possible - how severe their MS is likely to be.
There are 11 licensed drugs to reduce the relapse rate in MS. Choosing the right one for the right person at the right time can be challenging. Doctors need a tool to help them make an informed choice.
Doctors and scientists at the University of Edinburgh Anne Rowling Regenerative Neurology Clinic, with Stratified Medicine Scotland, are leading the FutureMS research study to try to predict disease severity in people with MS. We aim to help doctors prescribe the right medication at the right time for the right person. This is sometimes called ‘personalised medicine’.
FutureMS might help doctors decide the most appropriate treatment for people with MS. It might help to remove the uncertainty that a diagnosis of MS can bring.
This study is now closed to new recruitment. Follow-up visits and data analysis are still ongoing. We will not know the results of the study until this is complete. Thank you to all those who are taking part!